ETrade Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-27,559
| Closed | -$1.65M | – | 845 |
|
|
2018
Q2 | $1.65M | Sell |
27,559
-1,082
| -4% | -$64.7K | 0.05% | 214 |
|
|
2018
Q1 | $1.31M | Buy |
28,641
+1,587
| +6% | +$72.7K | 0.04% | 257 |
|
|
2017
Q4 | $1.08M | Buy |
27,054
+504
| +2% | +$20.1K | 0.03% | 331 |
|
|
2017
Q3 | $1.06M | Sell |
26,550
-3,275
| -11% | -$131K | 0.04% | 314 |
|
|
2017
Q2 | $1.29M | Sell |
29,825
-5,115
| -15% | -$220K | 0.05% | 212 |
|
|
2017
Q1 | $1.09M | Sell |
34,940
-4,307
| -11% | -$135K | 0.05% | 236 |
|
|
2016
Q4 | $991K | Sell |
39,247
-6,858
| -15% | -$173K | 0.05% | 240 |
|
|
2016
Q3 | $1.14M | Sell |
46,105
-6,739
| -13% | -$167K | 0.06% | 195 |
|
|
2016
Q2 | $1.08M | Buy |
52,844
+1,264
| +2% | +$25.7K | 0.06% | 199 |
|
|
2016
Q1 | $787K | Buy |
+51,580
| New | +$787K | 0.04% | 255 |
|